B
Biogen
IPO- Headquarters
- Cambridge, Massachusetts
- Founded
- 1978
- Type
- Public
Similar Companies
BridgeBio PharmaIPO
BridgeBio Pharma is a clinical-stage biopharmaceutical company developing therapies for genetic d...
Palo Alto, United States501–1000healthtech, biotech
Growth Equity·$1.2B·Jan 2024
ImmunovantIPO
Clinical-stage biopharmaceutical company developing FcRn inhibitor therapies for IgG-mediated aut...
New York, United States51–200healthtech, biotech
Angel·$585.0M·Oct 2019
ADC Therapeutics SA Common SharesIPO
Commercial-stage oncology company pioneering antibody drug conjugate therapies for cancer treatment.
Lausanne, Switzerland201–500healthtech, biotech
Series E·$501.0M·Jun 2019
Summit Therapeutics Inc.IPO
Biopharmaceutical oncology company focused on discovery, development, and commercialization of ca...
Miami, United States51–200healthtech, biotech
Corporate Round·$500.0M·Oct 2025
Biohaven Ltd. Common SharesIPO
Global clinical-stage biopharmaceutical company pursuing novel drug development platforms for rar...
New Haven, United States201–500healthtech, biotech
Venture Unknown·$493.6M·Aug 2020
Nektar TherapeuticsIPO
Research-based development stage biopharmaceutical company that discovers and develops innovative...
San Francisco, United States51–200biotech, immunotherapy
Corporate Round·$460.0M·Feb 2026